🔗 Share this article

The Nobel Prize in medical science was granted for revolutionary discoveries that illuminate how the body's defense network targets harmful pathogens while sparing the healthy tissues.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this accolade.

The research uncovered specialized "sentinels" within the immune system that eliminate rogue immune cells capable of attacking the organism.

The discoveries are now enabling new treatments for immune disorders and malignancies.

These laureates will divide a monetary award worth 11 million SEK.

Crucial Discoveries

"Their work has been decisive for understanding how the immune system operates and why we do not all suffer from severe self-attack conditions," stated the chair of the award panel.

This trio's research address a core question: In what way does the defense system protect us from countless invaders while leaving our own tissues unharmed?

The immune system employs white blood cells that search for signs of disease, including pathogens and bacteria it has not met before.

These cells employ sensors—known as recognition units—that are produced randomly in a vast number of combinations.

That gives the defense network the capacity to fight a broad range of threats, but the randomness of the mechanism inevitably creates immune cells that may target the host.

Security Guards of the Immune System

Scientists previously knew that some of these problematic defense cells were eliminated in the thymus—the site where immune cells mature.

This year's award honors the discovery of T-reg cells—described as the body's "security guards"—which patrol the system to neutralize other defenders that assault the healthy cells.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel added, "The discoveries have established a novel area of investigation and spurred the creation of new treatments, for example for cancer and immune disorders."

In cancer, regulatory T-cells block the body from attacking the tumor, so research are aimed at reducing their numbers.

In autoimmune diseases, trials are testing increasing T-reg cells so the body is no longer under attack. A similar approach could also be useful in reducing the risks of transplanted organ rejection.

Innovative Studies

Professor Shimon Sakaguchi, from a Japanese institution, performed tests on mice that had their immune gland extracted, leading to self-attack conditions.

He demonstrated that injecting immune cells from healthy mice could prevent the disease—suggesting there was a system for preventing immune cells from harming the body.

Dr. Brunkow, from the a research center in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were studying an inherited immune disorder in rodents and people that resulted in the discovery of a gene critical for how T-regs operate.

"Their pioneering research has revealed how the body's defenses is controlled by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," commented a prominent physiology expert.

"The work is a striking illustration of how fundamental biological study can have far-reaching consequences for human health."